RIPK3 and non-small cell lung carcinoma: In NSCLC cells with low RIPK3 expression, apoptosis and necroptosis are activated dose-dependently both with <10 Gy/fraction RT and ≥10 Gy/fraction ablative hypofractionated radiation therapy (HFRT).